Advances in Infectious Diseases and Clinical Microbiology during the COVID-19 Pandemic

Advances in Infectious Diseases and Clinical Microbiology during the COVID-19 Pandemic

The COVID-19 pandemic caused a change in the pattern of various infectious diseases. Evidence suggests that the same nonpharmaceutical interventions employed to prevent the transmission of SARS-CoV-2 likely led to the reduced incidence of influenza in various regions across the globe. However, the C...

Full description

Bibliographic Details
Format:	eBook
Language:	English
Published:	Basel MDPI - Multidisciplinary Digital Publishing Institute 2023
Subjects:	Humanities Social interaction adolescents antibiotic therapy antimicrobials antiviral appetite aspirin attitude bacteremia breakthrough infections children clinical outcome CMV retinitis coinfections Colombia comorbidities coronavirus COVID-19 dexamethasone diabetes mellitus disease severity duration elderly population emergency epidemiology epidural abscess female gender heart failure hemodialysis HIV infection hospital stay HPV infection HPV vaccine hyperlipidemia hypertension infectious diseases inflammatory factors inflammatory markers Ion Torrent knowledge latent tuberculosis infection Lebanon low molecular weight heparin mediterranean diet MinION monkeypox outbreak mortality multifocal n/a Nanopore neoplasm history neutralizing antibodies (NAbs) NSAID Omicron ophthalmological diseases parental knowledge perception Peru pharmacovigilance plasmapheresis primary practice public health pulmonary thromboembolism QuantiFERON-TB Gold Plus assay questionnaire safety SARS-CoV-2 Saudi Arabia sequencing side effects stress oxidative superinfections survey telemedicine therapeutic plasma exchange tocilizumab tuberculosis tuberculosis verrucosa cutis (TBVC) vaccine vaccine hesitancy vaccines variants
Online Access:	Open Access: DOAB: description of the publication Open Access: DOAB, download the publication

Similar Items

Screening for TB in Hospitalised Patients with Inflammatory Bowel Disease before Anti-TNF Therapy: Is QuantiFERON<sup>®</sup> Gold Testing Useful?
by: Jessica Lovatt, et al.
Published: (2021-04-01)

Clinical utility of QuantiFERON TB Gold Test in the diagnosis of latent tuberculosis infections
by: Salvatore Nisticò, et al.
Published: (2010-03-01)

Interferon-gamma release assays and tuberculin skin testing for diagnosing latent Mycobacterium tuberculosis infection in at-risk groups in Poland
by: Katarzyna Kruczak, et al.
Published: (2016-01-01)

Epidemic of tuberculosis in a high school in Northern Sardinia
by: Alessandra Bua, et al.
Published: (2012-01-01)

Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy
by: Chun-Yu Cheng, et al.
Published: (2015-09-01)

Implementing contact tracing for tuberculosis in Kyrgyz Republic and risk factors for positivity using QuantiFERON-TB Gold plus
by: Caroline Corbett, et al.
Published: (2020-10-01)

Tuberculin skin test and interferon-gamma release assay values are associated with antimicrobial peptides expression in polymorphonuclear cells during latent tuberculous infection
by: Julio E Castañeda-Delgado, et al.
Published: (2014-06-01)

Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa
by: Rosa Sloot, et al.
Published: (2020-10-01)

Diagnostic utility of QuantiFERON-TB gold (QFT-G) in active pulmonary tuberculosis
by: Ahmed Anwar, et al.
Published: (2015-01-01)

Latent tuberculosis in patients with hepatitis C infection before receiving antiretroviral drugs
by: Mahmoud Elhabashy, et al.
Published: (2018-01-01)

Multidrug-resistant tuberculosis outbreak in an Italian prison: tolerance of pyrazinamide plus levofloxacin prophylaxis and serial interferon gamma release assays
by: A. Bedini, et al.
Published: (2016-07-01)

Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country
by: Sara Debulpaep, et al.
Published: (2019-07-01)

Tuberculosis Infection Screening in 5468 Italian Healthcare Students: Investigation of a Borderline Zone Value for the QFT-Test
by: Anna Rita Corvino, et al.
Published: (2020-09-01)

Prevalence of latent tuberculosis infection among foreign students in Lübeck, Germany tested with QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold Plus
by: Elia Noemi Gallegos Morales, et al.
Published: (2017-05-01)

QuantiFERON® TB GOLD’ s applications in the tuberculosis disease
by: Maria Saladino, et al.
Published: (2014-06-01)

Utility of QuantiFERON-TB Gold In-Tube assay in adult, pulmonary and extrapulmonary, active tuberculosis diagnosis
by: Mohammed Azghay, et al.
Published: (2016-03-01)

Role of the QuantiFERON-TB gold in tube in ruling out tuberculosis in end stage renal disease patients receiving hemodialysis
by: Khaled H. Mohamed, et al.
Published: (2012-07-01)

Comparison between Quanti-FERON-TB Gold In-Tube test and tuberculin skin test for diagnosis of latent tuberculosis in children: A cross-section study
by: Keyghobad Ghadiri, et al.
Published: (2020-01-01)

Evaluation of a new tuberculosis-related interferon gamma release assay for tuberculosis infection diagnosis in Huzhou, eastern China
by: Fuchu Qian, et al.
Published: (2013-01-01)

Detection of latent tuberculosis infection in hemodialysis patients: Comparison between the quantiferon-tuberculosis gold test and the tuberculin skin test
by: Mona T. Hussein, et al.
Published: (2017-07-01)

O desafio da tuberculose na faixa etária pediátrica frente a novas técnicas diagnósticas The challenge of pediatric tuberculosis in face of new diagnostic techniques
by: Flavio R. Sztajnbok, et al.
Published: (2009-06-01)

Prevention of Congenital Cytomegalovirus Infection with Vaccines: State of the Art
by: Susanna Esposito, et al.
Published: (2021-05-01)

QuantiFERON® TB Gold IT in the diagnosis of active pulmonary TB
by: Clara Fabris, et al.
Published: (2010-03-01)

Characteristics Associated with Negative Interferon-γ Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013–2015
by: Duc T. Nguyen, et al.
Published: (2018-03-01)

Antiretroviral Treatment-Induced Decrease in Immune Activation Contributes to Reduced Susceptibility to Tuberculosis in HIV-1/Mtb Co-infected Persons
by: Katalin A. Wilkinson, et al.
Published: (2021-03-01)

Diez años de vacunación frente al virus del papiloma humano. De la dermatología a la oncología a través de la infectología
by: Fernando A. Moraga-Llop
Published: (2018-05-01)

Assessment of women's knowledge about HPV vaccination in the light of the HPV infection as a risk factor for cervical cancer
by: Arkadiusz Standyło, et al.
Published: (2020-09-01)

Prevalence of Latent Mycobacterium Tuberculosis Infection (LTBI) in Saudi Arabia; Population based survey
by: Hanan H. Balkhy, et al.
Published: (2017-07-01)

Mycobacterium tuberculosis-Specific T Cell Functional, Memory, and Activation Profiles in QuantiFERON-Reverters Are Consistent With Controlled Infection
by: Cheleka A. M. Mpande, et al.
Published: (2021-08-01)

Human Papilloma Virus Infection and Vaccination: Pre-Post Intervention Analysis on Knowledge, Attitudes and Willingness to Vaccinate Among Preadolescents Attending Secondary Schools of Palermo, Sicily
by: Claudio Costantino, et al.
Published: (2020-07-01)

Breast tuberculosis: A case report of primary type mammary tuberculosis
by: Giovanni Tazzioli, et al.
Published: (2019-12-01)

Functional, Antigen-Specific Stem Cell Memory (TSCM) CD4+ T Cells Are Induced by Human Mycobacterium tuberculosis Infection
by: Cheleka A. M. Mpande, et al.
Published: (2018-03-01)

Impact of socioeconomic status and living condition on latent tuberculosis diagnosis among the tribal population of Melghat: A cohort study
by: Rajpal S Kashyap, et al.
Published: (2016-01-01)

Predictors of low prevalence of latent tuberculosis infection among Egyptian health care workers at intensive care and bronchoscopy units
by: Hefzy, Enas Mamdouh, et al.
Published: (2016-10-01)

Comparison of QuantiFERON-TB gold in tube test versus tuberculin skin test for screening of latent tuberculosis infection in Saudi Arabia: A population-based study
by: Hanan H Balkhy, et al.
Published: (2016-01-01)

QuantiFERON-TB Gold In-Tube test in active tuberculosis patients and healthy adults
by: Benjawan Phetsuksiri, et al.
Published: (2018-10-01)

Methods for screening and prevention of HPV infection – a retrospective study
by: Catalina Diana Stanica, et al.
Published: (2021-03-01)

Utility of QuantiFERON tuberculosis gold-in-tube test for detecting latent tuberculosis infection among close household contacts of confirmed tuberculosis patients in Accra, Ghana
by: Gloria Ivy Mensah, et al.
Published: (2017-01-01)

QuantiFERON-TB Gold and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Children
by: Hossein Masoumi Asl, et al.
Published: (2015-09-01)

Risk factors for active tuberculosis in 938 QuantiFERON-positive schoolchildren in Mongolia: a community-based cross-sectional study
by: Davaasambuu Ganmaa, et al.
Published: (2019-06-01)